β2AR agonists are commonly used in acute respiratory infections, COPD, and asthma, a prescription pattern that was confirmed in this study by our examination of the common diagnostic codes among patients who received β2AR agonists. Here, ADRB2 is linked to chronic obstructive pulmonary disease.